Arcturus Therapeutics (ARCT) came out with a quarterly loss of $0.52 per share versus the Zacks Consensus Estimate of a loss of$1.58. This compares to loss of $1 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 67.09$0.34 per share when it actually produced a loss of $1.11, delivering a surprise of -226.47%.Over the last four quarters, the ...